IMR · ASX

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (ASX:IMR)

AU$1.47

 0.015 (1.031%)
ASX:Live
17/04/2025 04:10:20 PM
Recent Earnings upgrade Hammer Bullish HALO Price Momentum HALO Ords GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IMR Overview

IMR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About IMR

Website

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

Telephone

1.952.818.8400

Address

400 Gateway Boulevard Burnsville, MN 55337

Description

Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The firm offers the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator, Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter, and Vision-MR Dispersive Electrode, an ablation dispersive electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. The company was founded by Steven Wedan in 2006 and is headquartered in Burnsville, MN.

IMR Price Chart

Key Stats

Market Cap

AU$466.07M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.41 - 1.71

Trade Value (12mth)

US$38,077.00

1 week

0%

1 month

4.26%

YTD

1.03%

1 year

191.09%

All time high

2.85

Key Fundamentals

EPS 3 yr Growth

-9.20%

EBITDA Margin

%

Operating Cashflow

-$16m

Free Cash Flow Return

-206.50%

ROIC

-393.70%

Interest Coverage

-766.30

Quick Ratio

7.20

Other Data

Shares on Issue (Fully Dilluted)

236m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.05

IMR Announcements

Latest Announcements

Date Announcements

17 April 25

CE Mark Approval for Advantage-MR under EU's MDR

×

CE Mark Approval for Advantage-MR under EU's MDR

16 April 25

Change in substantial holding

×

Change in substantial holding

16 April 25

Change in substantial holding from CGF

×

Change in substantial holding from CGF

14 April 25

Notification regarding unquoted securities - IMR

×

Notification regarding unquoted securities - IMR

11 April 25

Imricor Commences VISABL-VT Clinical Trial

×

Imricor Commences VISABL-VT Clinical Trial

10 April 25

Notification of cessation of securities - IMR

×

Notification of cessation of securities - IMR

10 April 25

Annual Report to shareholders

×

Annual Report to shareholders

10 April 25

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

10 April 25

Notice of Annual Stockholders Meeting and CDI Voting Form

×

Notice of Annual Stockholders Meeting and CDI Voting Form

01 April 25

Becoming a substantial holder

×

Becoming a substantial holder

01 April 25

Becoming a substantial holder from CGF

×

Becoming a substantial holder from CGF

28 March 25

Cleansing Notice

×

Cleansing Notice

28 March 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

27 March 25

Application for quotation of securities - IMR

×

Application for quotation of securities - IMR

26 March 25

Application for quotation of securities - IMR

×

Application for quotation of securities - IMR

20 March 25

Successful Completion of A$70 Million Capital Raise

×

Successful Completion of A$70 Million Capital Raise

20 March 25

Proposed issue of securities - IMR

×

Proposed issue of securities - IMR

20 March 25

Equity Raising Presentation

×

Equity Raising Presentation

20 March 25

Reinstatement to Official Quotation

×

Reinstatement to Official Quotation

19 March 25

Suspension from Quotation

×

Suspension from Quotation

17 March 25

Trading Halt

×

Trading Halt

07 March 25

S&P DJI Announces March 2025 Quarterly Rebalance

×

S&P DJI Announces March 2025 Quarterly Rebalance

04 March 25

Submission of Second Module to FDA for PMA Products

×

Submission of Second Module to FDA for PMA Products

27 February 25

Appendix 4E and FY24 Financial Accounts

×

Appendix 4E and FY24 Financial Accounts

27 February 25

Imricor Releases FY24 Results

×

Imricor Releases FY24 Results

IMR Fundamentals

Per Share Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.12 -0.14 -0.13 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.12 -0.14 -0.13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 21.0 -25.3 8.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.10 -0.09 -0.05 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.11 -0.08 -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.0 11.4 37.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock -45.4 -22.8 -7.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.05 -0.05 -0.03 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.05 -0.05 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -68.3 -207.8 47.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 150 157 224 Lock Lock Lock
Basic m Lock Lock Lock Lock 150 157 224 Lock Lock Lock

Financial Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 17.2 -24.6 55.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 16 16 15 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.5 26.9 17.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -187.1 -181.3 -96.3 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 287 281 196 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -17 -16 -15 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.4 3.3 3.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,027.9 -2,598.4 -1,602.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -17 -17 -16 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.8 2.3 3.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,115.2 -2,738.1 -1,698.6 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -17 -23 -30 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -17 -23 -30 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.0 -30.4 -31.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,127.0 -3,675.6 -3,094.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -17 -13 -16 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 4 8 30 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -17 -13 -16 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.5 22.0 -19.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -20.5 -21.2 -16.3 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 1 16 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 14 8 22 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 4 10 21 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 10 6 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 6 17 29 Lock Lock Lock
Equity $m Lock Lock Lock Lock 8 -9 -8 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 11 1 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -53.1 -92.2 1,437.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -126.7 -272.3 -137.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -226.1 265.7 377.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -98.0 -247.7 -195.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -102.5 -386.8 -393.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -97.5 -221.8 -206.5 Lock Lock Lock

Ratios Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -93.0 -333.6 -766.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.1 -0.6 -0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -16.2 -116.1 -70.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.7 0.9 7.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.6 0.5 7.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 58.7 21.1 85.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -795.8 -284.1 -661.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 7.5 2.4 2.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.0 0.9 1.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.0 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 32.5 332.5 37.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.1 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.1 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -2,127.0 -3,675.6 -3,094.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -126.7 -272.3 -137.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -126.7 -272.3 -137.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.8 -1.0 -2.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -226.1 265.7 377.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -226.1 265.7 377.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 373.1 407.3 312.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 48.9 149.6 142.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 422.0 556.9 454.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 76.0 368.8 234.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 346.0 188.2 219.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.05%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IMR Shortsell

Frequently Asked Questions

The current share price of Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is AU$1.47.
The 52-week high share price for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is AU$1.71.
The 52-week low share price for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX)? is AU$0.41.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) does not pay a dividend.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) does not pay a dividend.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) has a franking level of 0.0%.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is classified in the Healthcare.
The current P/E ratio for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.